Miro E. Raeber
Impact in
- Immunology top 2%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Immunology 15
- T-cell and B-cell Immunology 11
- Immunotherapy and Immune Responses 3
-
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 4
- Co-authors
- Onur Boyman (21 shared papers)Yves Zurbuchen (11 shared papers)Dilara Şahin (2 shared papers)Daniela Impellizzieri (2 shared papers)Ufuk Karakus (2 shared papers)Jakob Nilsson (8 shared papers)Carlo Cervia (9 shared papers)Sarah Adamo (9 shared papers)
- Journals
- Nature Communications (3 papers)Allergy (3 papers)Science Translational Medicine (2 papers)Nature Immunology (2 papers)Nature (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Miro E. Raeber
23 papers receiving 2.3k citations
Miro E. Raeber's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 730
- Infectious Diseases 673
- Neurology 342
- Oncology 463
- Radiology, Nuclear Medicine and Imaging 105
Countries citing papers authored by Miro E. Raeber
This map shows the geographic impact of Miro E. Raeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miro E. Raeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miro E. Raeber more than expected).
Fields of papers citing papers by Miro E. Raeber
This network shows the impact of papers produced by Miro E. Raeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miro E. Raeber. The network helps show where Miro E. Raeber may publish in the future.
Co-authors
The 25 scholars most cited alongside Miro E. Raeber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 462 | |
| 2 | 2020 | 323 | |
| 3 | Persistent complement dysregulation with signs of thromboinflammation in active Long Covid Hit paper breakdown → | 2024 | 259 |
| 4 | 2018 | 179 | |
| 5 | Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome Hit paper breakdown → | 2022 | 168 |
| 6 | A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases Hit paper breakdown → | 2023 | 155 |
| 7 | 2021 | 110 | |
| 8 | 2020 | 108 | |
| 9 | 2019 | 77 | |
| 10 | 2020 | 73 | |
| 11 | 2022 | 62 | |
| 12 | 2021 | 60 | |
| 13 | 2022 | 49 | |
| 14 | 2015 | 43 | |
| 15 | 2018 | 42 | |
| 16 | 2014 | 40 | |
| 17 | 2024 | 40 | |
| 18 | 2022 | 39 | |
| 19 | 2023 | 37 | |
| 20 | 2020 | 23 |
About Miro E. Raeber
Miro E. Raeber is a scholar working on Immunology, Infectious Diseases, Oncology, Neurology and Rheumatology, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), COVID-19 Clinical Research Studies (4 papers), Immunotherapy and Immune Responses (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Long-Term Effects of COVID-19 (2 papers) and Systemic Lupus Erythematosus Research (1 paper). The work is most often cited by research in Immunology (730 citations), Infectious Diseases (673 citations), Neurology (342 citations), Oncology (463 citations) and Radiology, Nuclear Medicine and Imaging (105 citations). Miro E. Raeber has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Onur Boyman, Yves Zurbuchen, Dilara Şahin, Daniela Impellizzieri, Ufuk Karakus, Jakob Nilsson, Carlo Cervia, Sarah Adamo, C. Garrison Fathman and Ignacio Moraga. Their work appears in journals such as Nature Communications, Allergy, Science Translational Medicine, Nature Immunology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.